LUSARIS THERAPEUTICS, INC.
Profile
Company Names
LUSARIS THERAPEUTICS, INC.
Addresses
630 DAVIS DRIVE, SUITE 220, MORRISVILLE, NC 27560
Phone Numbers
617-778-2500
Entity Type:
CORPORATION
Industry:
PHARMACEUTICALS
Year Incorporated:
2021
State Incorporated:
DELAWARE
Total Amount Raised:
$60,156,164.00
Number of Funding Rounds:
1
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
1
2022-10-13
$60,156,164.00
$60,156,164.00
$0.00
Equity
People
First Name
Middle Name
Last Name
Titles
Related Companies
NEIL
BUCKLEY
EXECUTIVE OFFICER
RAMIN
FARZANEH-FAR
EXECUTIVE OFFICER
DANIEL
GRAU
DIRECTOR
ANDREW
LEVIN
EXECUTIVE OFFICER, DIRECTOR
IMMUNETICS, INC.
| ARVINAS HOLDING COMPANY, LLC
| SYNTHORX, INC.
| CLEANBREAK, INC.
| CLEAR CREEK BIO, INC.
| IMBRIA PHARMACEUTICALS, INC.
| ELIEM THERAPEUTICS, INC.
| ATHENEN THERAPEUTICS, INC.
| ARCUATE THERAPEUTICS, INC.
| AEROVATE THERAPEUTICS, INC.
| SANTI THERAPEUTICS, INC.
| CYTEK BIOSCIENCES, INC.
| METAGENOMI TECHNOLOGIES, LLC
| LUSARIS THERAPEUTICS, INC.
| SUPERLUMINAL MEDICINES, INC.
| NAVIGATOR MEDICINES, INC.
| AKTIS ONCOLOGY, INC.
| PAHR THERAPEUTICS, INC.
| LONESTAR MEDICINES, INC.
| SOLSTICE ONCOLOGY, INC.
| SLATE MEDICINES, INC.
| CLIMB BIO, INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#

